Home/Kimer Med/Rick Kiessig
RK

Rick Kiessig

Co‑Founder, CEO & CSO

Kimer Med

Therapeutic Areas

Kimer Med Pipeline

DrugIndicationPhase
BSV-001Dengue (all serotypes)Preclinical
BSV-002Influenza APreclinical
BSV-003Cytomegalovirus (CMV)Preclinical